Showing 1 - 1 results of 1 for search 'Mark Carlton', query time: 0.02s Refine Results
  1. 1
    CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trialResearch in context

    CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trialResearch in context by Nicola L. Brice, Mark Carlton, David H. Margolin, Martin Bexon, Kim L. Matthews, Lee A. Dawson, Aaron L. Ellenbogen, C. Warren Olanow, Jordan Dubow, Karl Kieburtz

    Published 2024-11-01
    Get full text
    Article

Search Tools: